Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chromosome 16 open reading frame 87 (C16orf87) is a poorly characterized human protein. Proteomic studies identify it as a component interacting with histone deacetylase complexes, including HDAC1 and HDAC2, suggesting a role in chromatin remodeling or epigenetic regulatory mechanisms[2][4][5]. It may act as a novel regulatory factor in the assembly and stabilization of HDAC-containing complexes, potentially affecting transcription, chromatin structure, and early development through modulation of ribonucleoprotein complexes[4][5]. C16orf87 contains a putative zinc-finger domain, hinting at possible DNA-binding activity and involvement in chromatin targeting[2]. The gene has been detected in rare fusion events with ATXN2 in cancer contexts, but no established link to therapeutic targeting, biomarker utility, or direct disease associations has been reported[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chromosome 16 open reading frame 87 (C16orf87).